The slip
PARKINSON RECEIPTno. 9141
24 Oct 2026, 23:59 UTCdopamine neurons, braak
predictionEHD1 in dopamine neurons tracks Braak Lewy-body stage
registereda16a4ac5fe7221e2
discovery-0.38 p=0.309 n=9
replication-0.51 p=0.165 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.38, p 0.309)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT4ce5ac5f90db35d120317cb1…
follows b4ed504bc5fb…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 9141: EHD1 in dopamine neurons, braak
- power
- full sample -0.42 (p 0.082, n 18), 95% CI -0.74 to +0.06. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.42 (p 0.082, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.49 (p 0.039, n 18). not the mix.
- skeptic
- leave-one-out range -0.52 to -0.35, sign flips 0; without severely affected donors -0.42 (p 0.082, n 18). robust.
- cell type
- strongest in oligodendrocytes: -0.60 (p 0.0089, n 18) vs -0.42 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for EHD1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up EHD1 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.47 p 0.091 (needs p < 2.3e-4)